Atlas Trials

Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy

Clinical trial NCT06285058 · UNKNOWN

Trial details

NCT number
NCT06285058
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
UNKNOWN
Study type
OBSERVATIONAL
Deep Learning ModelPathological Complete ResponseNon-small Cell Lung CancerNeoadjuvant Chemoimmunotherapy
Start date
2024-03-01
Primary completion
2025-12-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.